These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 8364015)

  • 1. LDL inhibits the mediation of cholesterol efflux from macrophage foam cells by apoA-I-containing lipoproteins. A putative mechanism for foam cell formation.
    Nakamura R; Ohta T; Ikeda Y; Matsuda I
    Arterioscler Thromb; 1993 Sep; 13(9):1307-16. PubMed ID: 8364015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effect of subspecies of lipoprotein containing apolipoprotein A-I on cholesterol efflux from cholesterol-loaded macrophages: functional correlation with lecithin: cholesterol acyltransferase.
    Ohta T; Nakamura R; Ikeda Y; Shinohara M; Miyazaki A; Horiuchi S; Matsuda I
    Biochim Biophys Acta; 1992 Nov; 1165(1):119-28. PubMed ID: 1420341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different effects of subclasses of HDL containing apoA-I but not apoA-II (LpA-I) on cholesterol esterification in plasma and net cholesterol efflux from foam cells.
    Ohta T; Saku K; Takata K; Nakamura R; Ikeda Y; Matsuda I
    Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):956-62. PubMed ID: 7600128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remodeling of HDL containing apoA-I but not apoA-II (LpA-I) by lipoprotein-deficient plasma and hepatic lipase: its effect on the structure and cellular cholesterol-reducing capacity of LpA-I.
    Ohta T; Ikeda Y; Hattori S; Matsuda I
    Biochim Biophys Acta; 1996 Sep; 1303(2):137-44. PubMed ID: 8856043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein A-I promotes cholesterol release and apolipoprotein E recruitment from THP-1 macrophage-like foam cells.
    Bielicki JK; McCall MR; Forte TM
    J Lipid Res; 1999 Jan; 40(1):85-92. PubMed ID: 9869653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux.
    Lee M; Calabresi L; Chiesa G; Franceschini G; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1475-81. PubMed ID: 12231569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sterol efflux is impaired from macrophage foam cells selectively enriched with 7-ketocholesterol.
    Gelissen IC; Brown AJ; Mander EL; Kritharides L; Dean RT; Jessup W
    J Biol Chem; 1996 Jul; 271(30):17852-60. PubMed ID: 8663356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of free apolipoprotein-mediated cellular lipid efflux by probucol.
    Tsujita M; Yokoyama S
    Biochemistry; 1996 Oct; 35(40):13011-20. PubMed ID: 8855936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of HepG2 cell-derived apolipoprotein A-I-containing lipoproteins on cholesteryl ester accumulation in macrophages.
    Kawano T; Hakamata H; Ohta T; Ding Y; Yoshida M; Ueda S; Horiuchi S
    Biochemistry; 1997 Aug; 36(32):9816-25. PubMed ID: 9245414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for impaired cellular cholesterol removal mediated by apo A-I containing lipoproteins in patients with familial lecithin: cholesterol acyltransferase deficiency.
    Ohta T; Nakamura R; Ikeda Y; Frohlich J; Takata K; Saito Y; Horiuchi S; Matsuda I
    Biochim Biophys Acta; 1994 Aug; 1213(3):295-301. PubMed ID: 8049242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic fate of apolipoprotein A-I-containing lipoproteins internalized into HepG2 cells: resecreted lipoproteins as a potent inducer for cholesterol efflux.
    Sasahara T; Kobori S; Kasho M; Sato Y; Nishikawa T; Yano T; Takeda H; Shichiri M
    Atherosclerosis; 1994 Apr; 106(2):179-90. PubMed ID: 8060378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of an acyl-coenzyme A:cholesterol acyltransferase inhibitor on HDL-induced cholesterol efflux from rat macrophage foam cells.
    Hakamata H; Miyazaki A; Sakai M; Sakamoto YI; Matsuda H; Kihara K; Horiuchi S
    FEBS Lett; 1995 Apr; 363(1-2):29-32. PubMed ID: 7729547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsins F and S block HDL3-induced cholesterol efflux from macrophage foam cells.
    Lindstedt L; Lee M; Oörni K; Brömme D; Kovanen PT
    Biochem Biophys Res Commun; 2003 Dec; 312(4):1019-24. PubMed ID: 14651973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced atheroprotection and lesion remodelling by targeting the foam cell and increasing plasma cholesterol acceptors.
    Son SH; Goo YH; Choi M; Saha PK; Oka K; Chan LC; Paul A
    Cardiovasc Res; 2016 Feb; 109(2):294-304. PubMed ID: 26487692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases-3, -7, and -12, but not -9, reduce high density lipoprotein-induced cholesterol efflux from human macrophage foam cells by truncation of the carboxyl terminus of apolipoprotein A-I. Parallel losses of pre-beta particles and the high affinity component of efflux.
    Lindstedt L; Saarinen J; Kalkkinen N; Welgus H; Kovanen PT
    J Biol Chem; 1999 Aug; 274(32):22627-34. PubMed ID: 10428843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.
    Rader DJ; Ikewaki K; Duverger N; Schmidt H; Pritchard H; Frohlich J; Clerc M; Dumon MF; Fairwell T; Zech L
    J Clin Invest; 1994 Jan; 93(1):321-30. PubMed ID: 8282802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance of smooth muscle cells to assembly of high density lipoproteins with extracellular free apolipoproteins and to reduction of intracellularly accumulated cholesterol.
    Komaba A; Li Q; Hara H; Yokoyama S
    J Biol Chem; 1992 Sep; 267(25):17560-6. PubMed ID: 1517206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting mitochondrial 18 kDa translocator protein (TSPO) regulates macrophage cholesterol efflux and lipid phenotype.
    Taylor JM; Allen AM; Graham A
    Clin Sci (Lond); 2014 Nov; 127(10):603-13. PubMed ID: 24814875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural modification of plasma HDL by phospholipids promotes efficient ABCA1-mediated cholesterol release.
    Hajj Hassan H; Blain S; Boucher B; Denis M; Krimbou L; Genest J
    J Lipid Res; 2005 Jul; 46(7):1457-65. PubMed ID: 15654121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lecithin:cholesterol acyltransferase reaction on cellular lipid released by free apolipoprotein-mediated efflux.
    Czarnecka H; Yokoyama S
    Biochemistry; 1995 Apr; 34(13):4385-92. PubMed ID: 7703252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.